Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Baumann

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Therapeutic Drug Monitoring|July 27, 2002
Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizerHenriette Hilleret, Pierre Voirol, Philippe Bovier, et al.
Clinical Pharmacokinetics|December 17, 2008
Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviourAnna-Britta Lind, Margareta Reis, Finn Bengtsson, et al.
Addictive Behaviors|September 3, 2005
Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screeningCharles Bonsack, Didier Camus, Nadine Kaufmann, et al.
European Journal of Clinical Pharmacology|April 29, 2004
Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjectsChin B Eap, Thierry Buclin, Elisabeth Hustert, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 12, 2010
Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with L- and D,L-methadoneDirk Wedekind, Stefan Jacobs, Iris Karg, et al.
Journal of Clinical Psychopharmacology|July 14, 2009
ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapineEveline Jaquenoud Sirot, Branka Knezevic, Gina Perla Morena, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 12, 2005
Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patientsCarlos A de Mendonça Lima, Pierre Baumann, Marlyse Brawand-Amey, et al.
Journal of Psychopharmacology (Oxford, England)|December 15, 2010
Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot studyGeorg Nikisch, Pierre Baumann, Beatrice Oneda, et al.
Therapeutic Drug Monitoring|February 14, 2025
How to Determine a Therapeutic Reference Range for a Psychotropic Drug Systematically? Recommendations of the TDM Task Force of the AGNPXenia M Hart, Friederike Amann, Pierre Baumann, et al.
Journal of Clinical Psychopharmacology|March 23, 2002
Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizersStefan Begré, Ulrich von Bardeleben, Dieter Ladewig, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Therapeutic Drug Monitoring|July 27, 2002
Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizerHenriette Hilleret, Pierre Voirol, Philippe Bovier, et al.
Clinical Pharmacokinetics|December 17, 2008
Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviourAnna-Britta Lind, Margareta Reis, Finn Bengtsson, et al.
Addictive Behaviors|September 3, 2005
Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screeningCharles Bonsack, Didier Camus, Nadine Kaufmann, et al.
European Journal of Clinical Pharmacology|April 29, 2004
Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjectsChin B Eap, Thierry Buclin, Elisabeth Hustert, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 12, 2010
Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with L- and D,L-methadoneDirk Wedekind, Stefan Jacobs, Iris Karg, et al.
Journal of Clinical Psychopharmacology|July 14, 2009
ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapineEveline Jaquenoud Sirot, Branka Knezevic, Gina Perla Morena, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 12, 2005
Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patientsCarlos A de Mendonça Lima, Pierre Baumann, Marlyse Brawand-Amey, et al.
Journal of Psychopharmacology (Oxford, England)|December 15, 2010
Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot studyGeorg Nikisch, Pierre Baumann, Beatrice Oneda, et al.
Therapeutic Drug Monitoring|February 14, 2025
How to Determine a Therapeutic Reference Range for a Psychotropic Drug Systematically? Recommendations of the TDM Task Force of the AGNPXenia M Hart, Friederike Amann, Pierre Baumann, et al.
Journal of Clinical Psychopharmacology|March 23, 2002
Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizersStefan Begré, Ulrich von Bardeleben, Dieter Ladewig, et al.
Pageof 10